Published Date：Nov. 2020
Industry：Medical Devices & Consumables
Pages：106 Table Number：125
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global PEGylated Drugs market in this environment. In terms of revenue, this research report indicated that the global PEGylated Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of PEGylated Drugs industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The ?Thermo Fisher Scientific aims at producing XX PEGylated Drugs in 2020, with XX % production to take place in global market, ????Merck accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of PEGylated Drugs Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in PEGylated Drugs Market? Thermo Fisher Scientific Merck Johnson & Johnson Creative PEGworks NOF Quanta BioDesign Celares Biomatrik Iris Biotech Laysan Bio ... ... Major Type of PEGylated Drugs Covered in XYZResearch report: Linkers Cross-Linkers Other Application Segments Covered in XYZResearch Market Cancer Chronic Kidney Diseases Hepatitis Multiple Sclerosis Hemophilia Gastrointestinal Disorders For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global PEGylated Drugs Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Linkers -Product Introduction and Major Manufacturers 1.1.2 Cross-Linkers -Product Introduction and Major Manufacturers 1.1.3 Other -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global PEGylated Drugs Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China PEGylated Drugs Market 3.1.1 Top Companies leading PEGylated Drugs Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China PEGylated Drugs Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU PEGylated Drugs Market 3.2.1 Top Companies leading PEGylated Drugs Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU PEGylated Drugs Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA PEGylated Drugs Market 3.3.1 Top Companies leading PEGylated Drugs Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA PEGylated Drugs Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan PEGylated Drugs Market 3.4.1 Top Companies leading PEGylated Drugs Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan PEGylated Drugs Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India PEGylated Drugs Market 3.5.1 Top Companies leading PEGylated Drugs Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India PEGylated Drugs Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia PEGylated Drugs Market 3.6.1 Top Companies leading PEGylated Drugs Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia PEGylated Drugs Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America PEGylated Drugs Market 3.7.1 Top Companies leading PEGylated Drugs Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America PEGylated Drugs Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 PEGylated Drugs Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on PEGylated Drugs Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global PEGylated Drugs Sales and Growth Rate (2021-2026) 5.2 Global PEGylated Drugs Sales Value and Growth Rate (2021-2026) 6 PEGylated Drugs Competitive Analysis 6.1 Thermo Fisher Scientific 6.1.1 Thermo Fisher Scientific Company Profiles 6.1.2 Thermo Fisher Scientific Product Introduction 6.1.3 Thermo Fisher Scientific PEGylated Drugs Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Merck 6.2.1 Merck Company Profiles 6.2.2 Merck Product Introduction 6.2.3 Merck PEGylated Drugs Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Johnson & Johnson 6.3.1 Johnson & Johnson Company Profiles 6.3.2 Johnson & Johnson Product Introduction 6.3.3 Johnson & Johnson PEGylated Drugs Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Creative PEGworks 6.4.1 Creative PEGworks Company Profiles 6.4.2 Creative PEGworks Product Introduction 6.4.3 Creative PEGworks PEGylated Drugs Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 NOF 6.5.1 NOF Company Profiles 6.5.2 NOF Product Introduction 6.5.3 NOF PEGylated Drugs Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Quanta BioDesign Celares Biomatrik 6.6.1 Quanta BioDesign Celares Biomatrik Company Profiles 6.6.2 Quanta BioDesign Celares Biomatrik Product Introduction 6.6.3 Quanta BioDesign Celares Biomatrik PEGylated Drugs Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 6.7 Iris Biotech Laysan Bio 6.7.1 Iris Biotech Laysan Bio Company Profiles 6.7.2 Iris Biotech Laysan Bio Product Introduction 6.7.3 Iris Biotech Laysan Bio PEGylated Drugs Production, Revenue (2015-2020) 6.7.4 SWOT Analysis 6.8 ... 6.8.1 ... Company Profiles 6.8.2 ... Product Introduction 6.8.3 ... PEGylated Drugs Production, Revenue (2015-2020) 6.8.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global PEGylated Drugs Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global PEGylated Drugs Sales (K Unit) by Type (2015-2026) Figure Global PEGylated Drugs Sales (K Unit) and Growth Rate (2015-2026) Figure Global PEGylated Drugs Sales Market Share (%) by Type (2019 -2020) Table Global PEGylated Drugs Sales Value (Million USD) by Type (2015-2026) Figure Global PEGylated Drugs Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global PEGylated Drugs Sales Value Market Share (%) by Type (2019-2020) Table Global PEGylated Drugs Sales (K Unit) by Application (2015-2026) Table China PEGylated Drugs Sales (K Unit) of Major Company (2015-2020) Table China PEGylated Drugs Sales Market Share of Major Company (2015-2020) Table China PEGylated Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure China PEGylated Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table China PEGylated Drugs Sales Value Share of Major Company (2015-2020) Table China PEGylated Drugs Price (USD/Unit), by Type (2019-2020) Table China PEGylated Drugs Sales (Unit) by Type (2015-2026) Figure China PEGylated Drugs Sales (Unit) by Type (2015-2026) Table EU PEGylated Drugs Sales (K Unit) of Major Company (2015-2020) Table EU PEGylated Drugs Sales Market Share of Major Company (2015-2020) Table EU PEGylated Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure EU PEGylated Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table EU PEGylated Drugs Sales Value Share of Major Company (2015-2020) Table EU PEGylated Drugs Price (USD/Unit), by Type (2019-2020) Table EU PEGylated Drugs Sales (Unit) by Type (2015-2026) Figure EU PEGylated Drugs Sales (Unit) by Type (2015-2026) Table USA PEGylated Drugs Sales (K Unit) of Major Company (2015-2020) Table USA PEGylated Drugs Sales Market Share of Major Company (2015-2020) Table USA PEGylated Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure USA PEGylated Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table USA PEGylated Drugs Sales Value Share of Major Company (2015-2020) Table USA PEGylated Drugs Price (USD/Unit), by Type (2019-2020) Table USA PEGylated Drugs Sales (Unit) by Type (2015-2026) Figure USA PEGylated Drugs Sales (Unit) by Type (2015-2026) Table Japan PEGylated Drugs Sales (K Unit) of Major Company (2015-2020) Table Japan PEGylated Drugs Sales Market Share of Major Company (2015-2020) Table Japan PEGylated Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure Japan PEGylated Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan PEGylated Drugs Sales Value Share of Major Company (2015-2020) Table Japan PEGylated Drugs Price (USD/Unit), by Type (2019-2020) Table Japan PEGylated Drugs Sales (Unit) by Type (2015-2026) Figure Japan PEGylated Drugs Sales (Unit) by Type (2015-2026) Table India PEGylated Drugs Sales (K Unit) of Major Company (2015-2020) Table India PEGylated Drugs Sales Market Share of Major Company (2015-2020) Table India PEGylated Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure India PEGylated Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table India PEGylated Drugs Sales Value Share of Major Company (2015-2020) Table India PEGylated Drugs Price (USD/Unit), by Type (2019-2020) Table India PEGylated Drugs Sales (Unit) by Type (2015-2026) Figure India PEGylated Drugs Sales (Unit) by Type (2015-2026) Table Southeast Asia PEGylated Drugs Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia PEGylated Drugs Sales Market Share of Major Company (2015-2020) Table Southeast Asia PEGylated Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia PEGylated Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia PEGylated Drugs Sales Value Share of Major Company (2015-2020) Table Southeast Asia PEGylated Drugs Price (USD/Unit), by Type (2019-2020) Table Southeast Asia PEGylated Drugs Sales (Unit) by Type (2015-2026) Figure Southeast Asia PEGylated Drugs Sales (Unit) by Type (2015-2026) Table South America PEGylated Drugs Sales (K Unit) of Major Company (2015-2020) Table South America PEGylated Drugs Sales Market Share of Major Company (2015-2020) Table South America PEGylated Drugs Sales Value (Million USD) of Major Company (2015-2020) Figure South America PEGylated Drugs Sales Value (Million USD) and Growth Rate (2015-2020) Table South America PEGylated Drugs Sales Value Share of Major Company (2015-2020) Table South America PEGylated Drugs Price (USD/Unit), by Type (2019-2020) Table South America PEGylated Drugs Sales (Unit) by Type (2015-2026) Figure South America PEGylated Drugs Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of PEGylated Drugs Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of PEGylated Drugs Figure Cost Structure of PEGylated Drugs in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global PEGylated Drugs Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global PEGylated Drugs Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table ?Thermo Fisher Scientific Profiles Table ?Thermo Fisher Scientific PEGylated Drugs Product Introduction Table ?Thermo Fisher Scientific PEGylated Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ?Thermo Fisher Scientific SWOT Analysis Table ????Merck Profiles Table ????Merck PEGylated Drugs Product Introduction Table ????Merck PEGylated Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Merck SWOT Analysis Table ????Johnson & Johnson Profiles Table ????Johnson & Johnson PEGylated Drugs Product Introduction Table ????Johnson & Johnson PEGylated Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Johnson & Johnson SWOT Analysis Table ????Creative PEGworks Profiles Table ????Creative PEGworks PEGylated Drugs Product Introduction Table ????Creative PEGworks PEGylated Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Creative PEGworks SWOT Analysis Table ????NOF Profiles Table ????NOF PEGylated Drugs Product Introduction Table ????NOF PEGylated Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????NOF SWOT Analysis Table ????Quanta BioDesign Celares Biomatrik Profiles Table ????Quanta BioDesign Celares Biomatrik PEGylated Drugs Product Introduction Table ????Quanta BioDesign Celares Biomatrik PEGylated Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Quanta BioDesign Celares Biomatrik SWOT Analysis Table ????Iris Biotech Laysan Bio Profiles Table ????Iris Biotech Laysan Bio PEGylated Drugs Product Introduction Table ????Iris Biotech Laysan Bio PEGylated Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure ????Iris Biotech Laysan Bio SWOT Analysis Table ????... Profiles Table ????... PEGylated Drugs Product Introduction Table ????... PEGylated Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
